Institute Of Tropical Medicine
- Address
- lock Available on a paid plan
HIV and Antiretroviral Research
At the Institute Of Tropical Medicine in Antwerp, clinical research in HIV infections focuses on improving treatment options and strengthening viral control for people living with HIV. Studies in this therapeutic area are evaluating new and existing antiretroviral strategies to support better long-term care.
- Testing simpler and more effective antiretroviral therapy approaches for adults with HIV
- Assessing long-acting treatment options for people with an incomplete response to oral therapy
- Evaluating new oral regimens for treatment-naïve adults living with HIV-1
This work aims to improve treatment effectiveness, support viral suppression, and expand options for different patient needs.
Bacterial Infections and Sexually Transmitted Disease Prevention
Research in bacterial infections at this site includes major efforts in sexually transmitted infections, especially among populations at higher risk. The studies are designed to reduce infection rates and better understand prevention strategies for chlamydia, gonorrhea, and syphilis.
- Evaluating doxycycline-based prevention for bacterial STIs in people living with HIV and in those using HIV-PrEP
- Studying whether different prevention schedules can lower infection risk more effectively
- Exploring the impact of post-exposure prevention on antimicrobial resistance
The goal is to improve STI prevention while also monitoring how prevention approaches may affect antibiotic resistance.
Viral Vaccines and Immunology
A strong part of the clinical research portfolio at the Department of Clinical Sciences involves virus diseases and vaccine research. These studies examine immune responses, safety, and real-world protection against infections such as influenza, respiratory syncytial virus, yellow fever, rabies, herpes simplex, and mpox.
- Testing vaccines to prevent influenza and improve protection in healthy volunteers
- Comparing immune responses to rabies and yellow fever vaccination by route of administration
- Assessing vaccine safety and immune response for RSV, mpox, and herpes simplex prevention
These trials aim to strengthen vaccine protection, refine vaccination strategies, and better understand immune responses across different viral infections.
Behavior, Chemsex-Related Drug Use, and Prevention Support
The site also conducts research in psychiatry and psychology, with a focus on behavior and behavior mechanisms linked to sexual health. Current studies examine craving and the use of chemsex-related drugs, looking at ways to support healthier behavior and reduce risk.
- Evaluating whether a medication plus counselling can reduce craving for chemsex-associated drugs
- Studying behavior-related factors that may influence prevention and treatment outcomes
- Supporting harm-reduction approaches for people affected by substance use in sexual health settings
This research is intended to improve behavioral support, inform prevention services, and help address substance use challenges connected to sexual health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 4 therapeutic areas and 15 of 61 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 61 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Institute Of Tropical Medicine5active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Institute Of Tropical Medicine10trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Institute Of Tropical Medicine
lock Showing 1 of 22 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 1/2, randomized, dose-finding/dose-confirmation study to evaluate the reactogenicity, safety and immunogenicity of mRNA-based multivalent seasonal influenza vaccine candidates administered in healthy younger and older adults | GlaxoSmithKline Biologicals | Phase I/II | Not Recruiting | Apr 2023 | Jul 2024 |
IMP list
lock Showing 1 of 61 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Emtricitabine | 3 | Unknown | 2019-08-05 | 2026-02-11 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.
